Emmanuel Odi
Internal Medicine · Birmingham, ALNPI 1215976451
Payments from drug & device makers
Across 489 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$792
- AstraZeneca$705
- AbbVie$701
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$529
- Johnson & Johnson$398
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,63599%
- Education$931%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 90 | $1,249 |
| Lilly USA, LLC | 49 | $792 |
| AstraZeneca | 44 | $705 |
| AbbVie(2 entities) | 62 | $701 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $529 |
| Johnson & Johnson | 20 | $398 |
| Amgen(2 entities) | 22 | $381 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $326 |
| Merck | 19 | $320 |
| GSK | 18 | $283 |
| Pfizer | 16 | $259 |
| Biohaven Pharmaceuticals, Inc. | 11 | $227 |
| Vivus LLC | 12 | $201 |
| Assertio Therapeutics, Inc. | 13 | $195 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $150 |
| Astellas Pharma US Inc | 6 | $148 |
| Boehringer Ingelheim | 7 | $118 |
| Amarin Pharma, Inc. | 7 | $116 |
| Eisai Inc. | 7 | $104 |
| Zyla Life Sciences, Inc. | 4 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Mannkind Corporation | 3 | $48 |
| Dexcom, Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Medtronic | 1 | $22 |
| Bayer | 1 | $21 |
| Novartis | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$7,728 in reported general payments places this provider in the 85th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Birmingham
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- William KirbyBirmingham$2.3M
- Jordan VaughnBirmingham$1.6M
- Stefanie KrickBirmingham$527K
- Ryan WeldonBirmingham$458K
- Ashraf KhanBirmingham$215K
- Robert LewisBirmingham$201K
- David WynneBirmingham$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.